Back to News
Market Impact: 0.35
Moderna stock just crashed 21% in a day; Here's why
Source: finbold.com
Healthcare & BiotechCompany Fundamentals
Moderna shares fell 17.57% on October 22, from $245.81 to $202.63, then declined a further 4.40% to $193.71 in Friday pre-market trading. The article provides no stated catalyst for the selloff.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
strongly negative
Sentiment Score
-0.55
Ticker Sentiment
MRNA-0.80
More News
- The real test for Moderna’s cancer vaccine isn’t about beating Keytruda. It’s keeping cancer from coming back in the long term.
- Oncologists Cheer Melanoma Data
- Investing.com’s stocks of the week
- Doctors call Moderna, Merck's cancer vaccine data a major advancement — even as stocks fall
- Moderna Stock Cools After Cancer Vaccine Data Leak
- Moderna leaked data was positive, what's hurting MRNA stock then?